Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

[Optimization of peptide-drug conjugates for targeted tumor therapy].

Mezõ G, Biri-Kovács B, Pethõ L, Sabine S, Kiss K, Oláhné Szabó R, Ranðeloviæ I, Tóvári J.

Magy Onkol. 2019 Dec 9;63(4):290-300. Epub 2019 Oct 21. Hungarian.

2.

Novel Crizotinib-GnRH Conjugates Revealed the Significance of Lysosomal Trapping in GnRH-Based Drug Delivery Systems.

Murányi J, Varga A, Gyulavári P, Pénzes K, Németh CE, Csala M, Pethő L, Csámpai A, Halmos G, Peták I, Vályi-Nagy I.

Int J Mol Sci. 2019 Nov 8;20(22). pii: E5590. doi: 10.3390/ijms20225590.

3.

Suitability of GnRH Receptors for Targeted Photodynamic Therapy in Head and Neck Cancers.

Pethő L, Murányi J, Pénzes K, Gurbi B, Brauswetter D, Halmos G, Csík G, Mező G.

Int J Mol Sci. 2019 Oct 11;20(20). pii: E5027. doi: 10.3390/ijms20205027.

4.

Erratum: In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinoma.

Cazzamalli S, Figueras E, Pethő L, Borbély A, Steinkühler C, Neri D, Sewald N.

ACS Omega. 2018 Dec 5;3(12):16743. doi: 10.1021/acsomega.8b03183. eCollection 2018 Dec 31.

5.

Overcharging Effect in Electrospray Ionization Mass Spectra of Daunomycin-Tuftsin Bioconjugates.

Pethő L, Mező G, Schlosser G.

Molecules. 2019 Aug 16;24(16). pii: E2981. doi: 10.3390/molecules24162981.

6.

In Vivo Antitumor Activity of a Novel Acetazolamide-Cryptophycin Conjugate for the Treatment of Renal Cell Carcinomas.

Cazzamalli S, Figueras E, Pethő L, Borbély A, Steinkühler C, Neri D, Sewald N.

ACS Omega. 2018 Nov 30;3(11):14726-14731. doi: 10.1021/acsomega.8b02350. Epub 2018 Nov 2. Erratum in: ACS Omega. 2018 Dec 05;3(12):16743.

7.

Protein expression profile of HT-29 human colon cancer cells after treatment with a cytotoxic daunorubicin-GnRH-III derivative bioconjugate.

Schreier VN, Pethő L, Orbán E, Marquardt A, Petre BA, Mező G, Manea M.

PLoS One. 2014 Apr 9;9(4):e94041. doi: 10.1371/journal.pone.0094041. eCollection 2014.

Supplemental Content

Loading ...
Support Center